Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Search results

1-10 results from 641 for query «oral»

1 November, 2017 5:00 AM Alembic Pharma completes US-based Orit Lab acquisition

Drug firm Alembic Pharmaceuticals through its wholly-owned subsidiary has completed acquisition of US-based generic drug developer Orit Laboratories LLC for an undisclosed sum. "Alembic Pharmaceuticals through its 100 per cent owned subsidiary, Alembic Pharmaceuticals Inc, has completed acquisition of West Caldwell, New Jersey USA-based generic drug developer 30

22 October, 2017 6:50 AM Migrant workers in Ekm prone to oral cancer, reveals study

KOCHI: Migrant workers in the district are facing a great risk of developing oral cancer, says a study conducted by the departments of public health dentistry, St Gregorios Dental College, Kothamangalam, and Kannur Dental College. According to the study, higher use of tobacco accentuates the cancer burden of the state as 42.27% reported pre-cancerous 44

16 October, 2017 5:32 AM Aarushi Talwar Murder Case: Trials and Travails of a Trial Court Judge

There exists a long list of cases which were under constant media glare and the trial court judgments were quite often overturned or modified by the superior courts. New Delhi: In a strongly-worded verdict, the Allahabad High Court came down heavily on a trial court judge for being "unmindful of the basic tenets of law" while convicting Rajesh and Nupur 49

12 October, 2017 2:42 AM Aarushi Talwar Murder Case: Allahabad High Court Verdict on Conviction of Parents Today

Judge S Lal’s order failed to bring a closure to the case and public opinion remains divided, even after five years of the conviction of Aarushi Talwar's parents. New Delhi: Five years after 14-year-old Aarushi Talwar and domestic help Hemraj were found murdered, Special CBI Judge S Lal held Aarushi’s parents Rajesh and Nupur Talwar guilty of murder 27

11 October, 2017 6:25 AM Lupin's US arm takes over Symbiomix Therapeutics

Drug major Lupin's US subsidiary has acquired Symbiomix Therapeutics for a total cash consideration of USD 150 million (nearly Rs 980 crore). Lupin had entered into an arrangement to acquire the company earlier this year. The acquisition has been made for a cash consideration of USD 150 million, including USD 50 million upfront payment and other time-based 30

25 September, 2017 7:52 PM Why was Z plus security removed when Jaya was in hospital, asks nephew

A year after the death of Jayalalithaa, her nephew on Monday said the Z plus security personnel were not present at Apollo Hospital when she was admitted there. Chennai: A year after the death of CM J Jayalalithaa, her nephew J Deepak on Monday said the Z plus security personnel were not present at Apollo Hospital when she was admitted there. In an interview 33

16 September, 2017 2:42 PM Zydus Nesher Pharma gets USFDA nod to market influenza drug

Drug firm Zydus Cadila said Nesher Pharmaceuticals, a subsidiary of its US arm, has received final approval from the US health regulator to market Oseltamivir used for treatment and prevention of influenza. "Zydus' Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received final approval from the USFDA to market Oseltamivir powder 29

13 September, 2017 9:00 AM Lupin's US arm recalls 12,888 bottles of ulcer drug in US

Drug firm Lupin's US arm, Lupin Pharmaceuticals Inc, is recalling 12,888 bottles of Famotidine for oral suspension used in treatment of ulcers from the American market. The reason for the recall is current Good Manufacturing Practise (CGMP) deviations, United States Food and Drug Administration (USFDA) said in its latest Enforcement Report. Lupin Pharmaceuticals 42

13 September, 2017 5:23 AM Dr Reddy's Laboratories up 2% on plan to for phase 2 trial of CA-170

Shares of Dr Reddy's Laboratories added 2 percent intraday Wednesday as the company is planning for phase 2 trial of CA-170. The company's wholly owned subsidiary Aurigene Discovery Technologies is planning to initiate a Phase 2 trial of CA-170, a PDL1-VISTA inhibitor to be conducted at sites in India. CA-170 is an oral small molecule targeting the immune 43

6 September, 2017 1:51 PM Patanjali ad targeting HUL soap brands stopped by HC

The Bombay High Court has asked Patanajali Ayurved not to air its toilet soap advertisement which allegedly attacked soap brands of Hindustan Unilever (HUL).     New Delhi: The Bombay High Court has asked Patanajali Ayurved not to air its toilet soap advertisement which allegedly attacked soap brands of Hindustan Unilever (HUL). Even from the digital 87